Hamilton Lane Advisors LLC Arcutis Biotherapeutics, Inc. Transaction History

Hamilton Lane Advisors LLC

  • $140 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022
SELL
$16.33 - $22.2 $854,826 - $1.16 Million
-52,347 Closed
0 $0
Q3 2021

Oct 14, 2021
SELL
$19.28 - $27.1 $942,001 - $1.32 Million
-48,859 Reduced 48.28%
52,347 $1.25 Million
Q2 2021

Jul 20, 2021
BUY
$24.42 - $34.75 $2.47 Million - $3.52 Million
101,206 New
101,206 $2.76 Million

Others Institutions Holding ARQT

# of Institutions
172
Shares Held
126M
Call Options Held
498K
Put Options Held
1.64M
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $560M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email